Parkinson’s Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats
Open Access
- 22 February 2022
- journal article
- research article
- Published by American Society for Microbiology in mSystems
- Vol. 7 (1) , e0119121
Abstract
Parkinson’s disease (PD) is the second most common neurodegenerative disorder and is known to be associated with altered gastrointestinal function and microbiota composition. We previously showed that the gut bacteria harboring tyrosine decarboxylase enzymes interfere with levodopa, the main treatment for PD (S. P. van Kessel, A. K. Frye, A. O. El-Gendy, M. Castejon, A. Keshavarzian, G. van Dijk, and S. El Aidy, Nat Commun 10:310, 2019).Keywords
All Related Versions
This publication has 79 references indexed in Scilit:
- phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census DataPLOS ONE, 2013
- Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencingNature Methods, 2013
- The SILVA ribosomal RNA gene database project: improved data processing and web-based toolsNucleic Acids Research, 2012
- FLASH: fast length adjustment of short reads to improve genome assembliesBioinformatics, 2011
- UCHIME improves sensitivity and speed of chimera detectionBioinformatics, 2011
- Uptake of Pramipexole by Human Organic Cation TransportersMolecular Pharmaceutics, 2010
- Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: Effective recovery of bacterial and archaeal DNA using mechanical cell lysisJournal of Microbiological Methods, 2010
- The immunoregulatory role of dopamine: An updateBrain, Behavior, and Immunity, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- MUSCLE: multiple sequence alignment with high accuracy and high throughputNucleic Acids Research, 2004